Companies complying with Investigational New Drug (IND)
The FDA's IND program permits pharmaceutical firms to obtain authorization for administering experimental drugs to humans and transporting them across state lines prior to marketing approval, enabling collection of safety and efficacy data.
21,965
companies
List of companies that comply with Investigational New Drug (IND)
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
 United States | Biotechnology Research | 22k | $4.1B | Investigational New Drug (IND) | |
United States | Hospitals and Health Care | 726 | Investigational New Drug (IND) | ||
United States | Manufacturing | 2.9k | Investigational New Drug (IND) | ||
United States | IT Services and IT Consulting | 315k | $6.3B | Investigational New Drug (IND) | |
 United Kingdom | Banking | 85k | $22B | Investigational New Drug (IND) | |
 Spain | Pharmaceutical Manufacturing | 60k | $15B | Investigational New Drug (IND) | |
 Canada | Non-profit Organizations | 1.3k | $11M | Investigational New Drug (IND) | |
United States | Medical Equipment Manufacturing | 77k | $19B | Investigational New Drug (IND) | |
 Netherlands | Government Administration | 2.8k | Investigational New Drug (IND) | ||
United States | Banking | 232k | Investigational New Drug (IND) |
Showing top companies out of 21,965 that comply with Investigational New Drug (IND). Get the full list on TheirStack.
Frequently asked questions